BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4005127)

  • 1. Comparison of single-dose pharmacokinetic and pharmacodynamic properties of two metoprolol Oros systems with different initial zero-order release rates.
    Warrington SJ; Barclay SP; John VA; Shotton PA; Good W
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):225S-230S. PubMed ID: 4005127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system.
    Kendall MJ; Jack DB; Woods KL; Laugher SJ; Quarterman CP; John VA
    Br J Clin Pharmacol; 1982 Mar; 13(3):393-8. PubMed ID: 7059440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multiple dose pharmacokinetic and pharmacodynamic evaluation of conventional and 19/285 Oros formulations of metoprolol in healthy volunteers.
    Grainger SL; John VA; Shotton PA; Smith SE
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):239S-244S. PubMed ID: 4005129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oros controlled-release formulations of metoprolol: an approach to the development of a system for once daily administration.
    Good W; Leeson LJ; Zak SL; Wagner WE; Meeker JB; Arnold JD
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):231S-238S. PubMed ID: 4005128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of site of drug delivery on the systemic availability of metoprolol: comparison of intragastric infusion and 14/190 Oros administration.
    Warrington SJ; Barclay SP; John VA; Shotton PA; Wardle HM; Good W
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):219S-224S. PubMed ID: 4005126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteers.
    van Steveninck AL; Pieters MS; Schoemaker HC; Breimer DD; Cohen AF
    Br J Clin Pharmacol; 1993 Feb; 35(2):114-20. PubMed ID: 8443028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic comparison of an osmotic release oral metoprolol tablet and the metoprolol conventional tablet.
    Feliciano NR; Bouvet AA; Redalieu E; Castellana J; Luders RC; Schwartz DJ; Shum L; Zak S; Arnold JD; Leese PT
    Am Heart J; 1990 Aug; 120(2):483-9. PubMed ID: 2382633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
    Plosker GL; Clissold SP
    Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multiple dose comparative study of the pharmacodynamic and pharmacokinetic behaviour of polymer-matrix and Oros dosage forms of oxprenolol in healthy volunteers.
    Woods KL; Jack DB; Kendall MJ; Halsey A; O'Donnell ML; Warrington SJ; John VA
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):177S-184S. PubMed ID: 4005120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol.
    Kendall MJ; John VA; Quarterman CP; Welling PG
    Eur J Clin Pharmacol; 1980 Feb; 17(2):87-92. PubMed ID: 7371709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osmotically controlled-delivery of metoprolol in man: in vivo performance of Oros systems with different durations of drug release.
    Godbillon J; Gerardin A; Richard J; Leroy D; Moppert J
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):213S-218S. PubMed ID: 4005125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
    Floris B; Paoletti G; Pelizza L; Bertulla A; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):139-43. PubMed ID: 1906434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximal exercise power after a single dose of metoprolol and of slow-release metoprolol.
    Folgering H; van Bussel M
    Eur J Clin Pharmacol; 1980 Oct; 18(3):225-9. PubMed ID: 7439241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of food on the absorption of metoprolol administered as an Oros drug delivery system to man.
    Lecaillon JB; Massias P; Schoeller JP; Abadie F
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):245S-249S. PubMed ID: 4005130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets.
    Sandberg A; Blomqvist I; Jonsson UE; Lundborg P
    Eur J Clin Pharmacol; 1988; 33 Suppl():S9-14. PubMed ID: 3371395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose pharmacokinetic and pharmacodynamic comparison of polymer-matrix (Slow Trasicor) and Oros dosage forms of oxprenolol in healthy volunteers.
    Bennett PN; Bennett J; Bradbrook I; Francis J; John VA; Rogers H; Turner P; Warrington SJ
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):171S-175S. PubMed ID: 4005119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable isotope methodology for studying the performance of metoprolol Oros tablets in comparison to conventional and slow release formulations.
    Richard J; Cardot JM; Godbillon J
    Eur J Drug Metab Pharmacokinet; 1994; 19(4):375-80. PubMed ID: 7737240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic comparison of a new controlled-release formulation of metoprolol with a traditional slow-release formulation.
    Oosterhuis B; Jonkman JH; Kerkhof FA
    Eur J Clin Pharmacol; 1988; 33 Suppl():S15-8. PubMed ID: 3371389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK with a conventional slow release preparation.
    Oosterhuis B; Jonkman J; Zuiderwijk P; Sollie F
    J Clin Pharmacol; 1990 Feb; 30(S2):S33-8. PubMed ID: 2312777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses.
    Lücker P; Moore G; Wieselgren I; Olofsson B; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S17-27. PubMed ID: 2312775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.